Analysts' Opinions Are Mixed on These Healthcare Stocks: Kineta (KA), Gilead Sciences (GILD) and Evotec AG (EVO)
Analysts Offer Insights on Healthcare Companies: Kineta (KA), Eli Lilly & Co (LLY) and Iovance Biotherapeutics (IOVA)
Kineta Analyst Ratings
Buy Rating for Kineta Backed by Promising Drug Trials and Solid Financial Performance
Promising Prospects for Kineta's VISTA-101 Trial and KVA12123 Monotherapy Drive Buy Rating
Analysts Offer Insights on Healthcare Companies: Nemaura Medical (NMRD), Kineta (KA) and Regeneron (REGN)
Kineta Analyst Ratings
H.C. Wainwright Keeps Their Buy Rating on Kineta (KA)
HC Wainwright & Co. Reiterates Buy on Kineta, Maintains $8 Price Target
HC Wainwright Starts Kineta at Buy With $8 Price Target
HC Wainwright & Co. Initiates Coverage On Kineta With Buy Rating, Announces Price Target of $8
Analysts Are Bullish on Top Healthcare Stocks: Kineta (KA), Invivyd (IVVD)
No Data